The Chelsea Recreation Center is a community center and athletic facility operated by the New York City Department of Parks and Recreation in Chelsea, Manhattan.

During the past decade, Chelsea Ctr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chelsea Ctr" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chelsea Ctr" are "HIV Infections" (14 trials), "Cytomegalovirus Retinitis" (1 trials), "HIV Wasting Syndrome" (1 trials), "Hepatitis C" (1 trials) and "Pneumonia, Pneumocystis Carinii" (1 trials). Many other conditions were trialed in "Chelsea Ctr" in a lesser frequency.

Most popular intervention types in "Chelsea Ctr" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Efavirenz" (5 trials), "Indinavir sulfate" (5 trials), "Didanosine" (4 trials), "Nelfinavir mesylate" (4 trials) and "Ritonavir" (4 trials). Other intervention names were less common.

The vast majority of trials in "Chelsea Ctr" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Chelsea Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Chelsea Ctr, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chelsea Ctr, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".